Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 12
Encontrada(s) 1 página(s)

RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Integrated microphotonic platform for highly sensitive virus detection

  • La Grasta, A.
  • De Carlo, M.
  • Passaro, V.M.N.
  • Dell'Olio, F.
  • Gómez-Gómez, María Isabel|||0000-0001-7548-209X
  • Griol Barres, Amadeu
  • Gómez-Herreros, Estefania|||0009-0002-9474-6171
  • Martínez, Alejandro|||0000-0001-5448-0140
[EN] Chip-scale micro-photonic biosensors have matured significantly over the past two decades, with various platforms developed for detecting biomarkers, including proteins in biological fluids. The COVID-19 pandemic has further accelerated research in virus detection, leading to the development of resonant and interferometric biosensors for identifying viruses like SARS-CoV-2. Despite these advancements, there remains a need for technical solutions that ensure point-of-care features such as low cost, rapid response, and low limit-of-detection (LoD). This paper presents an integrated silicon nitride microphotonic platform based on ring resonator technology, specifically designed for highly sensitive virus detection. The sensors, fabricated using strip and slot waveguides, are tested under flow conditions using ethanol and BSA-antiBSA solutions to evaluate bulk and surface sensitivity. The results indicate that the slot waveguide-based ring resonators exhibit the highest sensitivity. The platform uses functionalization protocols to immobilize specific antibodies for detecting SARS-CoV-2. The sensor successfully identifies the target analyte at concentrations as low as 1.5 nM, with a LoD of 36 pM using in situ functionalization, underscoring the importance of antibody orientation through an intermediate protein A layer. These results demonstrate the platform's potential for rapid and sensitive virus diagnosis and represent a significant step toward the development of portable, point-of-care diagnostic technologies for infectious disease monitoring., A.G. and M. G. acknowledge financial support from the European Commission under grant agrrement D 101093042, HORIZON-CL4-2022 PHOTONGATE project and A. G, and A.M. acknowledge partial funding from the Conselleria d'Educacio, Universitats i Ocupacio under the NIRVANA Grant (PROMETEO Program, CIPROM/2022/14) .
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Development of Photonic Multi-Sensing Systems Based on Molecular Gates Biorecognition and Plasmonic Sensors: The PHOTONGATE Project

  • Nieves-Paniagua, Óscar|||0000-0001-8112-7334
  • Ortiz de Zárate-Díaz, David|||0000-0003-4127-9338
  • Aznar, Elena|||0000-0003-0361-3876
  • Caballos-Gómez, María Isabel
  • Garrido-García, Eva María
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
  • Barat Baviera, José Manuel|||0000-0001-8487-7114
  • Gómez-Gómez, María Isabel|||0000-0001-7548-209X
  • Griol Barres, Amadeu
  • Dortu, Fabian
  • Bernier, Damien
  • Mengual-Chuliá, Beatriz
  • López-Labrador, F. Xavier
  • Sloth, Jens J.
  • Loechner, Katrin
  • Duedahl-Olesen, Lene
  • Prado, Natalia
  • Hervello, Martín
  • Fuentes López, Ana
  • Fernández Segovia, Isabel
  • Salcedo, Jaime
  • Recuero, Sara
  • Simón, Simón
  • Fernández Blanco, Ana
  • Peransi, Sergio
[EN] This paper presents the concept of a novel adaptable sensing solution currently being developed under the EU Commission-founded PHOTONGATE project. This concept will allow for the quantification of multiple analytes of the same or different nature (chemicals, metals, bacteria, etc.) in a single test with levels of sensitivity and selectivity at/or over those offered by current solutions. PHOTONGATE relies on two core technologies: a biochemical technology (molecular gates), which will confer the specificity and, therefore, the capability to be adaptable to the analyte of interest, and which, combined with porous substrates, will increase the sensitivity, and a photonic technology based on localized surface plasmonic resonance (LSPR) structures that serve as transducers for light interaction. Both technologies are in the micron range, facilitating the integration of multiple sensors within a small area (mm2). The concept will be developed for its application in health diagnosis and food safety sectors. It is thought of as an easy-to-use modular concept, which will consist of the sensing module, mainly of a microfluidics cartridge that will house the photonic sensor, and a platform for fluidic handling, optical interrogation, and signal processing. The platform will include a new optical concept, which is fully European Union Made, avoiding optical fibers and expensive optical components., The micro-nanofabrication capabilities required in the PHOTONGATE project- 101093042 are funded by the Pluri-Regional FEDER funding Plan 2014-2020 European Commission. This research project has received funding from the European Union¿s HORIZON-CL4-2022 research and innovation programme under grant agreement ID 101093042, PHOTONGATE project
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

SARS-COV-2 viral RNA detection through oligonucleotide-capped nanoporous anodic alumina supports.

  • López-Palacios, Alba|||0000-0002-4397-277X
  • Caballos-Gómez, María Isabel
  • Hernández-Montoto, Andy|||0000-0001-5623-9836
  • Sancenón Galarza, Félix|||0000-0002-5205-7135
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
  • Aznar, Elena|||0000-0003-0361-3876
  • Aranda-Sobrino, María Nieves
  • Calbuig, Eva
  • Gómez-Ruiz, María Dolores
  • Tormo-Mas, M.A.
  • Peman, Javier
  • Climent Terol, Estela
[EN] We describe herein a sensor containing nanoporous anodic alumina (NAA) as sensing platform to identify SARSCOV-2 RNA using a gating mechanism. The system is based on NAA that contains a fluorescent dye (Rhodamine B; RhB) and is capped with an oligonucleotide sequence that hybridize specifically a region of SARS-CoV-2 genome. In the presence of RNA from SARS-COV-2 virus, the oligonucleotide of the surface is displaced, uncapping the pores, and producing a delivery of RhB. The detection of the virus is achieved measuring the fluorescence of the fluorophore. The nanosensor demonstrates to be highly sensitive and selective in aqueous buffers and in biological media, having a limit of detection (LOD) of 50 ± 30 copies mL-1 of SARS-CoV-2 RNA extracted from patients. Moreover, preliminary results using 18 real nasopharyngeal swab samples indicate the potential of the system to differentiate between infected and non-infected patients. Compared to the conventional RT-PCR method, in our system there is no need for sample pretreatment or RNA isolation, providing diagnostic outcomes within 60 mins while maintaining a high level of reliability, This study was sponsored by the Spanish Government (projects PID2021-126304OB-C41 (DOROTHY), PID2021-128141OB-C22 (ANTIVIBEM), and PID2021-122875OB-100 (MCUI/AEI/ FEDER, UE)), the Generalitat Valenciana (project no.2 RD 180/2020, CIPROM/ 2021/007), Supera COVID-19 Fund (DIACOVID project), the Universitat Polit`ecnica de Val`encia− Instituto de Investigacion ¿ Sanitaria La Fe (IISLaFe) (SARS-COV-2-SEEKER and VISION-COV projects). This research project has received funding from the European Union s HORIZON-CL4- 2022 research and innovation programme under grant agreement ID 101093042, PHOTONGATE project. Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or European Research Council. Neither the European Union nor th e granting authority can be held responsible for them. This work was supported by the European Research Council (ERC) via Advanced Grant (101052997, EDISON). Also, the project has received funding from the European Union s HORIZON-CL4-2022 research and innovation programme under grant agreement ID 101093042, PHOTONGATE project. A.L.P. thanks the Ministerio de Universidades for his predoctoral grant (FPU20/05297). E. C. thanks the Instituto de Salud Carlos III (Miguel Servet 2023 CP23/00086). Scheme 1 was done with BioRender.com. The Medicaments Research Ethics Committee, CEIm of University and Polytechnic La Fe Hospital of Valencia (2021-012-1) approved the use of samples from human patients.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Targeted detection of Mycobacterium tuberculosis MPT64 antigen using an antibody-coated nanoporous anodic alumina biosensor: A novel approach for tuberculosis screening

  • Caballos, Isabel
  • Climent Terol, Estela
  • Gil-Brusola, Ana
  • Hernández-Montoto, Andy|||0000-0001-5623-9836
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
  • Aznar, Elena|||0000-0003-0361-3876
[EN] Tuberculosis (TB) is a chronic condition caused by Mycobacterium tuberculosis. According to WHO's Global Tuberculosis Report 2024, TB has again become the leading cause of death from a single infectious agent, surpassing COVID-19 in 2023 and 2024 in terms of infectious disease deaths. Due to its high infectivity and serious effects, timely diagnosis and treatment are crucial for controlling its spread. This study presents a fluorogenic biosensor for detecting M. tuberculosis MPT64 antigen using gated nanoporous anodic alumina (NAA). NAA material is loaded with rhodamine B and capped with an antibody against MPT64 protein. The presence of MPT64 induces antibody displacement due to the specific recognition and subsequent release of rhodamine B to the medium that is detected by fluorescence measurement. The biosensor is physicochemically characterized by scanning electron microscopy and X-ray spectroscopy. The biosensor achieves a limit of detection (LOD) of 1.32 nM (0.032 mg L-1) for MPT64 protein and demonstrated high selectivity through testing against various antigens from other viral pathogens and bacterial species. The efficacy of the biosensor is further validated with grown mycobacteria from clinical samples. The developed approach offers three key aspects: (i) selective detection of active TB by targeting the secreted MPT64 protein using gated nanomaterials; (ii) a rapid response (60 min); and (iii) a cost-effective design suitable for resource-limited settings. This biosensor shows great potential as a tool for the clinical diagnosis of active tuberculosis., We thank PID2024-155683OB-C41 and PID2021-126304OB-C41 from the Ministerio de Ciencia, Innovacion y Universidades and AEI/10.13039/501100011033 (co-financed by the European Regional Development Fund) , and CIPROM/2021/007 (to R. M.-M.) from the Generalitat Valenciana. This research was also supported by CIBER, Instituto de Salud Carlos III (group CB07/01/2012) . I.-C. thanks the Instituto de Salud Carlos III for her predoctoral fellowship (IFI21/00008) . We thank electron microscopy service of UPV for their support. R.M.M. thanks to the European Union's Horizon EUROPE research and innovation programme under grant agreement No 101093042. E. C. thanks the Instituto de Salud Carlos III for funding the proyects Miguel Servet 2023 CP23/00086 and PI24_01239, both co-funded by the European Union.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Multiplexed Microphotonic Ring Resonator Platform for Simultaneous Detection of SARS-CoV-2 Spike Protein and Respiratory Syncytial Virus-F Protein

  • La Grasta, Annabella
  • Dell'Olio, Francesco
  • Gómez-Gómez, María Isabel|||0000-0001-7548-209X
  • Griol Barres, Amadeu
  • Gómez-Herreros, Estefania|||0009-0002-9474-6171
  • Martínez, Alejandro|||0000-0001-5448-0140
[EN] The persistent burden imposed by SARS-CoV-2, respiratory syncytial virus (RSV), and other respiratory viruses highlights the demand for real-time, label-free diagnostics capable of multipathogen detection. Despite numerous proposals, existing biosensors have yet to achieve the trifecta of sub-nanomolar sensitivity, simultaneous targeting, and a truly compact footprint. Here, we show a multiplexed photonic biosensor based on cascaded microring resonators (MRRs) that can detect two different viral glycoproteins, such as the SARS-CoV-2 spike protein and the RSV-F protein, at sub-nanomolar concentrations. Three strip-waveguide rings (radii =99, 100, 101 mu m; TE mode at 1310 nm) were designed via finite-element modeling and fabricated on a Si3N4 -on-insulator platform using e-beam lithography and inductively coupled plasma reactive ion etching (ICP-RIE). Preliminary results demonstrate a quality factor of the order of 10(5) and a mean bulk sensitivity value of 150 nm/RIU, evaluated in gradually concentrated ethanol solutions flowing on the sensor surface. A common bus waveguide enables wavelength-division multiplexing (WDM). Selective, oriented immobilization of anti-spike and anti-F antibodies is achieved through a protein A interfacial layer, while the central ring is intentionally left bare as an on-chip reference. By sweeping the wavelength of a continuous wave (CW) laser across each resonance, real-time resonance shifts are monitored and quantified via Lorentzian peak fitting. By functionalizing distinct rings with viral proteins-specific antibodies, our chip achieves detection limits of approximately 0.16 nM for the SARS-CoV-2 spike protein and 0.14 nM for the RSV-F protein, matching or surpassing the performance of conventional single-target optical biosensors. Our design allows the analysis of multiple viral antigens in parallel, reducing sample volume and overall test duration. Moreover, an on-chip reference ring ensures robust signal stability by compensating for nonspecific effects, thereby enhancing accuracy and reproducibility. These findings underscore the promise of integrated photonics to reshape point-of-care diagnostics, especially in decentralized or resource-limited settings. We anticipate that this platform's versatility can be extended to detect additional pathogens or biomolecules, providing a scalable and cost-effective tool for rapid clinical decision-making and epidemiological surveillance., The work of Annabella la Grasta was supported by the Project nanoPoc-Point-of-Care Tests based on Lab-on-Chip Nanophotonic Devices for Quality and Safety of the Surgical Site, funded by the Ecosistema dell Innovazione Tuscany Health Ecosystem under the Cascade Call, under Project ECS00000017. The work of Amadeu Griol was supported in part by European Commission through the HORIZONCL4-2022 PHOTONGATE Project under Grant 101093042 and in part by the Conselleria d Educació, Universitats i Ocupació through the NIRVANA Grant (PROMETEO Program) under Grant CIPROM/2022/14. The work of María Isabel Gómez-Gómez was supported by European Commission through the HORIZON-CL4-2022 PHOTONGATE Project under Grant 101093042. The work of Alejandro Martínez was supported by the Conselleria d Educació, Universitats i Ocupació through the NIRVANA Grant (PROMETEO Program) under Grant CIPROM/2022/14.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

A writing protocol with ambiguity resilience in nanoscale systems

  • Arias-Gonzalez, J. R.|||0000-0001-6802-0874
[EN] Writing is a directional, stochastic process by which an information substrate is constructed. It involves typing characters in a chain one at a time in the presence of memory. Unless editing is possible, plain writing fixes typed characters along the chain, a stepwise equilibration whose history influences successive characters. Here, we present a writing protocol in nanoscale systems that optimizes the interpretation of already generated error containing information to adequately influence the next character to type. Near the noise level, as characterized by the thermal energy, and in the presence of positive feedback, this resilient protocol presents higher entropy than that in which errors can be corrected but reduces the entropy of plain writing. For negative feedback, it presents lower entropy than both plain writing and writing with editing. When the noise level is low enough, the entropy becomes negative, which reflects an underlying phase transition at low temperatures., This work has been supported by the European Union s HORIZON-CL4-2022 research and innovation program under Grant Agreement ID 101093042, PHOTONGATE project.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Anthracene-Modified Nanoporous Silica Nanoparticles for ATP Detection and Salivary Diagnostics in Parkinson&apos, s Disease

  • Ahi, E.E.
  • Climent Terol, Estela
  • Beyret, Cansu
  • Caglayan, Mehmet Gokhan
  • Coban, Burak
  • Yilmaz, Rezzak
  • Durmus, Mahmut
  • Martí-Centelles, Vicente|||0000-0002-9142-9392
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
[EN] ATP is an essential biological molecule, and abnormal levels are linked to various diseases. In this study, we developed an optical sensor array consisting of an anthracene-modified MCM-41 mesoporous nanoparticle-based hybrid organic-inorganic material to detect ATP in a TRIS-HCl buffer (pH 7). To create the sensor, we synthesized MCM-41 silica nanoparticles and functionalized them with aminoanthracene and imidazolium-anthracene groups. The fluorescence responses of the optical sensor array were recorded and analyzed by using a pattern recognition protocol, specifically linear discriminant analysis, to distinguish between ATP, ADP, AMP, and potential interferents. Quantitative regression analysis of ATP in TRIS-HCl was performed using artificial neural networks, which yielded an acceptable error rate of 7.8%. The sensor array was also evaluated for discrimination of Parkinson's disease (PD) from healthy controls, based on pattern recognition of ATP-related analytes in saliva samples from 24 patients with PD and 23 healthy controls. The results showed that the MCM-41 mesoporous silica nanoparticle-based sensor array can discriminate PD by pattern recognition with 73.7% sensitivity and 83.3% specificity., The diagnostic part of this study is supported by the Ankara University Scientific Research Projects Coordination Office (TSA-2023-2648 and TSA-2025-3825). V.M.-C. acknowledges financial support from the Project CIDEGENT/2020/031 funded by the Generalitat Valenciana, Project ESGENT/2024/ 001 funded by the Generalitat Valenciana, project PID2024- 157188OB-I00 funded by MICIU/AEI/10.13039/ 501100011033 and FEDER A way to make Europe, project PID2020-113256RA-I00 funded by MICIU/AEI/10.13039/ 501100011033, and project CNS2023-144879 funded by MICIU/AEI/10.13039/501100011033 and European Union NextGenerationEU/PRTR. R.M.-M. acknowledges the European Union s Horizon EUROPE research and innovation program under grant agreement no. 101093042, project PID2024-155683OB-C41 funded by MICIU/AEI/10.13039/ 501100011033 and FEDER A way to make Europe, project PID2021-126304OB-C41 funded by MICIU/AEI/10.13039/ 501100011033 and FEDER A way to make Europe, and project PROMETEO CIPROM/2021/007 funded by Generalitat Valenciana. E.C. thanks the Instituto de Salud Carlos III for founding the projects Miguel Servet 2023 CP23/00086 and PI24_01239, both cofunded by the European Union.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

SARS-CoV-2 N protein IgG antibody detection employing nanoporous anodized alumina: A rapid and selective alternative for identifying naturally infected individuals in populations vaccinated with spike protein (S)-based vaccines

  • Esteve-Sánchez, Yoel|||0000-0002-6845-1110
  • Hernández-Montoto, Andy|||0000-0001-5623-9836
  • Marcos Martínez, María Dolores|||0000-0001-7079-8589
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
  • Aznar, Elena|||0000-0003-0361-3876
  • Tormo-Mas, M.A.
  • Peman, Javier
  • Eva Calbuig
  • Gomez, Maria Dolores
  • Climent Terol, Estela
[EN] Methods to detect naturally infected individuals, especially during or after a pandemic, are valuable in populations with a high rate of vaccination. Having in mind that after the COVID-19 pandemic people has been vaccinated against the virus by Spike protein (S)-based vaccines, we present in this paper a novel nanosensor based on gated nanoporous anodic alumina (NAA) material to detect naturally infected individuals in populations with high rates of vaccination. The nanosensor developed is based on a protein-capped nanomaterial for the identification of IgG antibodies that can detect nucleocapsid protein (N) of SARS-CoV-2. The NAA material has been loaded with an indicator (Rhodamine B (RhB)) and the pores of the material have been blocked with SARS-CoV-2 nucleocapsid protein (N) attached to a specific aptamer. In presence of antibodies against this antigen, the pores are uncapped, triggering the dye release and a fluorescent signal as a result. The biosensor has been tested in vitro and simulated serum for IgG detection, proving a detection limit of 1 mu g/mL. Moreover, specificity assays with N proteins from other coronaviruses have proved the robustness and efficacy of this nanosensor. Finally, the system has been tested on samples from patients that contained SARS-CoV-2 antibodies, demonstrating its potential for the discrimination of individuals that have been vaccinated or infected by SARS-CoV-2 virus., This research was supported by projects PID2021-126304OB-C41, PID2021-128141OB-C22, and PID2021-122875OB-100 funded by MCIN/AEI/10.13039/501100011033/and by European Regional Development Fund-A way of doing Europe. This work was also funded by the Generalitat Valenciana (project no.2 RD 180/2020, CIPROM/2021/007) , Santander and CRUE Supera COVID-19 Fund (DIACOVID project) , the Universitat Politecnica de Valencia-Instituto de Investigacion Sanitaria La Fe (IIS-LaFe) (SARS-COV-2-SEEKER and VISION-COV projects) . R.M thanks to the European Union's Horizon EUROPE Research and Innovation Program (grant agreement No 101093042) . Y.E.-S. acknowledges the Ministerio de Universidades for his predoctoral grant (FPU20/05297) . E.C. thanks the Instituto de Salud Carlos III (Miguel Servet 2023 CP23/00086) . Scheme 1 done with BioRender.com . The use of clinical samples from patients was approved by the Drug Research Ethics Committee, CEIm of Hospital Universitari i Politecnic La Fe of Valencia (2021-012-1) . In all cases was obtained an informed oral consent from all participants or next of kin prior to the research.r E.-S. acknowledges the Ministerio de Universidades for his predoctoral grant (FPU20/05297) . E.C. thanks the Instituto de Salud Carlos III (Miguel Servet 2023 CP23/00086) . Scheme 1 done with BioRender.com . The use of clinical samples from patients was approved by the Drug Research Ethics Committee, CEIm of Hospital Universitari i Polite`cnic ` cnic La Fe of Valencia (2021-012-1) . In all cases was obtained an informed oral consent from all participants or next of kin prior to the research.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Aptamer-Capped Nanoporous Anodic Alumina for SARS-CoV-2 Spike Protein Detection

  • Caballos-Gómez, María Isabel
  • López-Palacios, Alba|||0000-0002-4397-277X
  • Hernández-Montoto, Andy|||0000-0001-5623-9836
  • Aznar, Elena|||0000-0003-0361-3876
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
  • Aranda, María Nieves
  • Pla, Luis
  • Santiago Felipe, Sara
  • Tormo-Mas, María Ángeles
  • Pemán, Javier
  • Gómez-Ruiz, María Dolores
  • Calbuig, Eva
  • Sánchez-Sendra, Beatriz
  • Francés-Gómez, Clara
  • Geller, Ron
[EN] The COVID-19 pandemic, which began in 2019, has highlighted the importance of testing and tracking infected individuals as a means of mitigating the spread of the virus. In this context, the development of sensitive and rapid methods for the detection of SARS-CoV-2, the virus responsible for COVID-19, is crucial. Here, a biosensor based on oligonucleotide-gated nanomaterials for the specific detection of SARS-CoV-2 spike protein is presented. The sensing system consists of a nanoporous anodic alumina disk loaded with the fluorescent indicator rhodamine B and capped with a DNA aptamer that selectively binds the SARS-CoV-2 spike protein. The system is initially evaluated using pseudotype virus systems based on vesicular stomatitis virus carrying different SARS-CoV-2 S-proteins on their surface. When the pseudotype virus is present, the cap of the solid is selectively removed, triggering the release of the dye from the pore voids to the medium. The nanodevice demonstrated its ability to detect pseudotype virus concentrations as low as 7.5 center dot 10(3) PFU mL. In addition, the nanodevice is tested on nasopharyngeal samples from individuals suspected of having COVID-19., This study was supported by the Spanish Government (projects PID2021-126304OB-C41, and PID2021-122875OB-100 (MCUI/AEI/FEDER, UE)), the Generalitat Valenciana (project no.2 RD 180/2020, CIPROM/2021/007), Supera COVID-19 Fund (DIACOVID project), the Universitat Politecnica de Valencia-Instituto de Investigacion Sanitaria La Fe (IIS-LaFe) (SARS-COV-2-SEEKER and VISION-COV projects), and by the European Commission -NextGenerationEU, through CSIC's Global Health Platform (PTI Salud Global) to Ron Geller. The project leading to this application has received funding from the European Union's Horizon EUROPE research and innovation programme under grant agreement No 101093042. Isabel Caballos thanks the Instituto de Salud Carlos III for her predoctoral fellowship (IFI21/00008). Alba Lopez-Palacios thanks the Ministerio de Universidades for her predoctoral grant (FPU20/05297). Ron Geller holds a Ramon y Cajal fellowship from the Spanish Ministerio de Economia y Competitividad (RYC-2015-17517). Figure 1 done with BioRender.com. The use of samples from human subjects was approved by the Medicaments Research Ethics Commmittee, CEIm of Hospital Universitari i Politecnic La Fe (no. 2021-012-1). Informed written consent was obtained from all participants or next of kin prior to the research.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Boosting sensing performance through near-field engineering in low-Q metasurfaces

  • Alvarez-Sanchis, Jose Antonio|||0000-0002-5015-5401
  • Máñez-Espina, Luis Manuel|||0000-0002-3633-3734
  • Mengual Chulia, Teresa|||0000-0001-9609-2234
  • Griol Barres, Amadeu
  • Diaz Rubio, Ana|||0000-0002-0115-1834
[EN] Dielectric metasurfaces have introduced a new paradigm for substance detection by exploiting their resonant properties to enhance light¿matter interaction. This enhancement can be used for sensing either through refractive index changes or through absorption-based mechanisms. Most works focus on high¿quality factor resonators, aiming to increase field confinement in the vicinity of the resonant structure to improve sensitivity. In this work, we explore an alternative approach based on low¿quality factor, fully dielectric metasurfaces, with engineered modes to enhance near-field concentration. We investigate different topologies that, despite their low quality factors, achieve sensitivity and detection performance beyond what is typically reported for low¿Q structures in the literature. This improvement is enabled by near-field engineering of the evanescent modes, allowing us to control the spatial distribution of the electromagnetic field and maximize its overlap with the analyte. Our results show that careful mode engineering provides a powerful strategy to boost sensing performance without relying on ultra-high-Q resonances., Agencia Estatal de Investigación (PID2024-162261NB-I00, CNS2024-15471); Generalitat Valenciana (CIPROM/2022/14); Universitat Politècnica de València (PAID-01-23, POLISABIO2024-P18); European Commission (101093042).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Label-Free Detection of Respiratory Syncytial Virus in Clinical Nasopharyngeal Swab Samples Using a Silicon-Nitride Slot Microring Resonator

  • La Grasta, Annabella
  • Dell'Olio, Francesco
  • Gómez-Gómez, María Isabel|||0000-0001-7548-209X
  • Griol Barres, Amadeu
  • Gómez-Herreros, Estefania|||0009-0002-9474-6171
  • Martínez, Alejandro|||0000-0001-5448-0140
[EN] We report a silicon-nitride slot-waveguide microring resonator functionalized with monoclonal antibodies against the respiratory-syncytial-virus (RSV) fusion (F) protein for label-free, real-time detection of RSV. The 100 ¿m-radius slotted ring exhibits a loaded quality factor of 3.5 × 104 and a bulk sensitivity of 275 nm/RIU at 1310 nm. Langmuir fitting of recombinant F-protein titrations (0.05¿3 nM) gives an equilibrium dissociation constant KD = 5.4 × 10-2 nM and ¿¿max = 7.3 nm (R² = 0.997), yielding a limit-of-detection of 31 pM and a linear dynamic range spanning three orders of magnitude. When challenged with nasopharyngeal swab extracts from RSV-positive patients, the sensor produces wavelength shifts of 0.35¿1.45 nm that correlate quantitatively with viral load over > 10³-fold concentration range and show 100% concordance with RT-qPCR on three clinical specimens. The wash-free assay requires low volumes of samples and no labeling, and it is fully compatible with disposable CMOS-compatible photonic chips, underscoring its potential for near-patient RSV surveillance during seasonal outbreaks., We acknowledge financial support from the European Commission under grant agreement No. 101093042 (HORIZON-CL4-2022 PHOTONGATE project). A.G. and A.M. also acknowledge partial funding from the Conselleria d'Educació, Universitats i Ocupació under the NIRVANA Grant (PROMETEO Program, CIPROM/2022/14).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Aptamer-capped nanoporous anodic alumina for SARS-CoV-2 spike protein detection

  • Caballos, Isabel
  • Aranda, María Nieves
  • López-Palacios, Alba
  • Pla, Luis
  • Santiago-Felipe, Sara
  • Hernández-Montoto, Andy
  • Tormo-Mas, María Ángeles
  • Pemán, Javier
  • Gómez-Ruiz, María Dolores
  • Calabuig, Eva
  • Sánchez-Sendra, Beatriz
  • Francés-Gómez, Clara
  • Geller, Ron
  • Aznar, Elena
  • Martínez-Máñez, Ramón
The COVID-19 pandemic, which began in 2019, has highlighted the importance of testing and tracking infected individuals as a means of mitigating the spread of the virus. In this context, the development of sensitive and rapid methods for the detection of SARS-CoV-2, the virus responsible for COVID-19, is crucial. Herein, a biosensor based on oligonucleotide-gated nanomaterials for the specific detection of SARS-CoV-2 spike protein is presented. The sensing system consists of a nanoporous anodic alumina disk loaded with the fluorescent indicator rhodamine B and capped with a DNA aptamer that selectively binds the SARS-CoV-2 spike protein. The system is initially evaluated using pseudotype virus systems based on vesicular stomatitis virus carrying different SARS-CoV-2 S-proteins on their surface. When the pseudotype virus is present, the cap of the solid is selectively removed, triggering the release of the dye from the pore voids to the medium. The nanodevice demonstrated its ability to detect pseudotype virus concentrations as low as 7.5·103 PFU mL. In addition, the nanodevice is tested on nasopharyngeal samples from individuals suspected of having COVID-19., This study was supported by the Spanish Government (projects PID2021-126304OB-C41, and PID2021-122875OB-100 (MCUI/AEI/FEDER, UE)), the Generalitat Valenciana (project no.2 RD 180/2020, CIPROM/2021/007), Supera COVID-19 Fund (DIACOVID project), the Universitat Politècnica de València−Instituto de Investigación Sanitaria La Fe (IIS-LaFe) (SARS-COV-2-SEEKER and VISION-COV projects), and by the European Commission –NextGenerationEU, through CSIC's Global Health Platform (PTI Salud Global) to Ron Geller. The project leading to this application has received funding from the European Union's Horizon EUROPE research and innovation programme under grant agreement No 101093042. Isabel Caballos thanks the Instituto de Salud Carlos III for her predoctoral fellowship (IFI21/00008). Alba López-Palacios thanks the Ministerio de Universidades for her predoctoral grant (FPU20/05297). Ron Geller holds a Ramon y Cajal fellowship from the Spanish Ministerio de Economía y Competitividad (RYC-2015-17517)., Peer reviewed